XML 54 R45.htm IDEA: XBRL DOCUMENT v3.23.3
Stock-Based Compensation - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Millions
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 29, 2022
Aug. 09, 2022
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value $ 4.5        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value $ 25.68 $ 7.21      
Common Stock, Par or Stated Value Per Share $ 0.0001   $ 0.0001    
Aggregate fair value of restricted stock $ 2.9        
Common stock shares issued 24,139,078   17,405,231    
Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount $ 11.1        
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition 2 years 9 months 3 days        
Disc Medicine Inc [Member]          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]          
Common Stock, Par or Stated Value Per Share       $ 0.1096 $ 0.1096
Restricted Common Stock [Member]          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]          
Common stock shares issued 63,061        
Restricted Common Stock [Member] | Founders And Certain Employees [Member] | Disc Medicine Inc [Member]          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]          
Common Stock, Par or Stated Value Per Share $ 0.0001